EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity

Alexandra Moore, Amanda K Burrows, Wayne S Rosenkrantz iD, Rudayna M Ghubash, Giselle Hosgood

Veterinary Dermatology · 2023

DOI: 10.1111/vde.13189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Dermatology, 2023. Verfasst von Alexandra Moore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Animal Dermatology Clinic Perth, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Insect Bites and Stings, Bee Venoms, Hypersensitivity, Anaphylaxis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hymenoptera envenomation occurs frequently in people and dogs and can trigger anaphylaxis. Venom immunotherapy (VIT) is the only preventive treatment for Hymenoptera hypersensitivity and is indicated for people with severe adverse reactions to insect stings. Rush VIT is an accelerated VIT protocol in people. This has not been reported in dogs.

Objectives

The objective of the study was to evaluate the safety of modified rush VIT. Animals Twenty client‐owned dogs with Hymenoptera hypersensitivity based on a history of adverse reactions to Hymenoptera envenomation and a positive intradermal test to honey bee and/or paper wasp venom. Materials and Methods Dogs received incremental doses of venom via subcutaneous injection one day per week for three consecutive weeks until the maintenance dose was achieved. Vital signs were recorded every 30 min prior to venom administration. Adverse reactions were categorised as localised or grade I–IV systemic reactions.

Results

Nineteen of 20 dogs (95%) completed rush VIT. One dog experienced a grade III systemic adverse reaction and was withdrawn from the study. No adverse reactions occurred in 10 of 20 dogs (50%). Localised and grade I–II systemic reactions occurred in nine of 20 dogs (45%), including nausea (n = 5), injection site pruritus (n = 3) and diarrhoea and lethargy (n = 1). Conclusions and Clinical Relevance Modified rush VIT in dogs was well‐tolerated and should be considered for dogs with Hymenoptera hypersensitivity. Larger studies are needed to evaluate the efficacy of VIT in dogs for preventing hypersensitivity reactions to insect stings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insect Bites and StingsBee VenomsHypersensitivityAnaphylaxisDesensitization, ImmunologicHymenopteraDog DiseasesHumansDogsAnimalsImmunotherapy

Stichwörter der Autor:innen

Hymenopteraadverse reactionanaphylaxishypersensitivityrush venom immunotherapy

Substanzen

Bee Venoms

Autor:innen und Institutionen

  • Animal Dermatology Clinic Perth, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia.
  • Animal Dermatology Clinic, Tustin, California, USA.
  • Animal Dermatology Clinic, Marina del Rey, California, USA.
  • College of Veterinary Medicine, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia.

ORCID-Profile: Wayne S Rosenkrantz

Zitieren

APA

Moore, A., Burrows, A. K., Rosenkrantz, W. S., Ghubash, R. M., & Hosgood, G. (2023). Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity. Veterinary Dermatology. https://doi.org/10.1111/vde.13189

Vancouver

Moore A, Burrows AK, Rosenkrantz WS, Ghubash RM, Hosgood G. Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity. Veterinary Dermatology. 2023. doi:10.1111/vde.13189

BibTeX
@article{Moore2023,
  author = {Moore, Alexandra and Burrows, Amanda K and Rosenkrantz, Wayne S and Ghubash, Rudayna M and Hosgood, Giselle},
  title = {Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity},
  journal = {Veterinary Dermatology},
  year = {2023},
  doi = {10.1111/vde.13189}
}
Kostenlos starten →